Active Ingredient(s): Gemtuzumab Ozogamicin
FDA Approved: * May 17, 2000
Pharm Company: * WYETH PHARMS INC
Category: Cancer

Gemtuzumab ozogamicin, sold under the brand name Mylotarg, is an antibody-drug conjugate (a drug-linked monoclonal antibody) that is used to treat acute myeloid leukemia.[4][5] The most common grade 3 and higher adverse reactions that occurred during Induction 1 and Intensification 2 in ≥ 5% of people who received gemtuzumab ozogamicin were infection, febrile neutropenia, decreased appetite, hyperglycemia, mucositis, hypoxia, hemorrhage, increased transam... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
2 Discussions

Dosage List

Mylotarg 5 mg/5ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 0008-4510
Wyeth Pharmaceuticals Inc., a Subsidiary of Pfizer Inc.

Popular Topics

Mylotarg and Increased Mortality Risk

My mom died two weeks after receiving two doses of mylotarg in May of 2010. Since her death certificate says her death w...